0001601830S-3ASREX-FILING FEES 0001601830 2025-02-12 2025-02-12 0001601830 1 2025-02-12 2025-02-12 0001601830 2 2025-02-12 2025-02-12 0001601830 3 2025-02-12 2025-02-12 0001601830 4 2025-02-12 2025-02-12 0001601830 5 2025-02-12 2025-02-12 0001601830 6 2025-02-12 2025-02-12 0001601830 7 2025-02-12 2025-02-12 0001601830 8 2025-02-12 2025-02-12 iso4217:USD
Exhibit 107
CALCULATION OF FILING FEE TABLES
Form
S-3
(Form Type)
Recursion Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
 
                 
    
Security
Type
 
Security
Class Title
 
Fee
Calculation
Rule
 
Amount
Registered
 
Proposed
Maximum
Offering
Price Per
Unit
 
Maximum
Aggregate
Offering
Price
 
Fee
Rate
 
Amount of
Registration
Fee
 
Newly Registered Securities
                 
Fees to Be Paid   Equity   Class A Common Stock, par value $0.00001 per share   Rule 457(r)   (1)(2)   (3)   (3)   (4)   (3)(4)
                 
Fees to Be Paid   Equity   Preferred Stock, par value $0.00001 per share   Rule 457(r)   (1)(2)   (3)   (3)   (4)   (3)(4)
                 
Fees to Be Paid   Debt   Debt Securities   Rule 457(r)   (1)(2)   (3)   (3)   (4)   (3)(4)
                 
Fees to Be Paid   Equity   Depositary Shares   Rule 457(r)   (1)(2)   (3)   (3)   (4)   (3)(4)
                 
Fees to Be Paid   Equity   Warrants   Rule 457(r)   (1)(2)   (3)   (3)   (4)   (3)(4)
                 
Fees to Be Paid   Other   Subscription Rights   Rule 457(r)   (1)(2)   (3)   (3)   (4)   (3)(4)
                 
Fees to Be Paid   Other   Purchase Contracts   Rule 457(r)   (1)(2)   (3)   (3)   (4)   (3)(4)
                 
Fees to Be Paid   Other   Units   Rule 457(r)   (1)(2)   (3)   (3)   (4)   (3)(4)
           
   
Total Offering Amounts
   
$
   
$
           
   
Total Fees Previously Paid
       
           
   
Total Fee Offsets
       
           
   
Net Fee Due
             
$
 
(1)
An indeterminate aggregate initial offering price and number of securities of each identified class is being registered as may from time to time be offered, issued or sold at indeterminate prices. In addition, an indeterminate number of securities that may be issued upon exercise, settlement, conversion or exchange of any offered securities, or pursuant to anti-dilution adjustments, is being registered. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities.
(2)
Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this registration statement shall also cover any additional shares of the registrant’s securities that become issuable by reason of any share splits, share dividends or similar transactions.
(3)
The proposed maximum per security and aggregate offering prices per class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.D. of Form S 3 under the Securities Act. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities, or that are issued in units.
(4)
In accordance with Rules 456(b) and 457(r) under the Securities Act, the registrant is deferring payment of the entire registration fee. Any registration fees will be paid subsequently on a
“pay-as-you-go”
basis.